Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR3 | P46089 | 1/20 | 0.45 |
| ▸ | LIMK1 | P53667 | 1/20 | 0.40 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.40 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.38 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.37 |
| ▸ | EGFR | P00533 | 2/20 | 0.36 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.35 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.35 |
| ▸ | GABRP | O00591 | 1/20 | 0.35 |
| ▸ | GABRD | O14764 | 1/20 | 0.35 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.35 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.35 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.35 |
| ▸ | GABRA5 | P31644 | 1/20 | 0.35 |
| ▸ | GABRA3 | P34903 | 1/20 | 0.35 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.35 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.35 |
| ▸ | GABRA4 | P48169 | 1/20 | 0.35 |
| ▸ | GABRE | P78334 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17740734 | 0.79 | GPR3 (0.45) | GPR3LIMK1CDK5CDK5R1KDM4E | |
| SCHEMBL20457808 | 0.79 | GPR3 (0.45) | GPR3LIMK1CDK5CDK5R1EGFR | |
| SCHEMBL17109969 | 0.79 | GPR3 (0.45) | GPR3LIMK1CDK5CDK5R1EGFR | |
| SCHEMBL14949584 | 0.79 | LIMK1 (0.51) | GPR3LIMK1CDK5CDK5R1KDM4E | |
| SCHEMBL16902379 | 0.76 | NPC1 (0.46) | GPR3LIMK1CDK5CDK5R1MAPT | |
| SCHEMBL17044919 | 0.75 | GPR3 (0.45) | GPR3LIMK1CDK5CDK5R1KDM4E | |
| SCHEMBL17463988 | 0.75 | GPR3 (0.41) | GPR3LIMK1CDK5CDK5R1EGFR | |
| SCHEMBL14629295 | 0.75 | GPR3 (0.41) | GPR3LIMK1CDK5CDK5R1KDM4E | |
| SCHEMBL18194539 | 0.75 | MAPT (0.42) | LIMK1KDM4EMAPTRAB9ASMN1; SMN2 | |
| SCHEMBL24056925 | 0.74 | GPR3 (0.48) | GPR3LIMK1CDK5CDK5R1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119452060-A | Material for electronic devices | 默克专利有限公司 | 2025-02-14 | — | — | CN | disclosed |
| WO-2021112478-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF | 덕산네오룩스 주식회사 | 2021-06-10 | — | — | WO | disclosed |
| US-20170352447-A1 | NOVEL HETEROCYCLIC COMPOUNDS AND ORGANIC LIGHT-EMITTING DIODE INCLUDING THE SAME | SFC CO., LTD. (KR) | 2017-12-07 | — | — | US | disclosed |
| US-20170352447-A1 | NOVEL HETEROCYCLIC COMPOUNDS AND ORGANIC LIGHT-EMITTING DIODE INCLUDING THE SAME | SFC CO., LTD. (KR) | 2017-12-07 | — | — | US | disclosed |
| US-20160322585-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2016-11-03 | — | — | US | disclosed |
| US-20160322585-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | SAMSUNG SDI CO., LTD. (KR) | 2016-11-03 | — | — | US | disclosed |
| US-9181270-B2 | Method of making sulfide compounds | UNIVERSAL DISPLAY CORPORATION (US) | 2015-11-10 | — | — | US | disclosed |
| US-20150246928-A1 | METHOD OF MAKING SULFIDE COMPOUNDS | UNIVERSAL DISPLAY CORPORATION (US) | 2015-09-03 | — | — | US | disclosed |
| WO-2015105315-A1 | FUSED-RING COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | 삼성에스디아이 주식회사 | 2015-07-16 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150246928-A1 | METHOD OF MAKING SULFIDE COMPOUNDS | CBS, SCLY, QSOX1 | GPR3 562/4885LIMK1 2673/4885CDK5 1033/4885 |
| US-20160322585-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE INCLUDING THE SAME | CRY1, CRY2, CCNE2 | GPR3 3366/4885LIMK1 1225/4885CDK5 75/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.